MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma.
about
Epigenetic Regulation of Epidermal Stem Cell Biomarkers and Their Role in Wound HealingProtein-Coding Genes' Retrocopies and Their Functions.Pleomorphic adenoma gene 1 mediates the role of karyopherin alpha 2 and has prognostic significance in hepatocellular carcinoma.MicroRNA-492 expression promotes the progression of hepatic cancer by targeting PTEN.Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer.Identification of a set of miRNAs differentially expressed in transiently TIA-depleted HeLa cells by genome-wide profiling.Effect of BRAF mutational status on expression profiles in conventional papillary thyroid carcinomasThe role of microRNAs in the biology of rare diseases.A cross comparison of technologies for the detection of microRNAs in clinical FFPE samples of hepatoblastoma patientsMicroRNA expression profiling of mature ovarian teratomas.miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs.Genome-wide analysis of long noncoding RNA (lncRNA) expression in hepatoblastoma tissues.Gene polymorphisms of micrornas in Helicobacter pylori-induced high risk atrophic gastritis and gastric cancer.Genetics and epigenetics of hepatoblastoma.Multi-platform microRNA profiling of hepatoblastoma patients using formalin fixed paraffin embedded archival samples.MicroRNA expression patterns and signalling pathways in the development and progression of childhood solid tumours.MiR-492 is functionally involved in Oxaliplatin resistance in colon cancer cells LS174T via its regulating the expression of CD147.MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression.Myeloid zinc-finger 1 (MZF-1) suppresses prostate tumor growth through enforcing ferroportin-conducted iron egress.Pseudogenes in gastric cancer pathogenesis: a review article.miR-492G>C polymorphism (rs2289030) is associated with overall survival of hepatocellular carcinoma patients.MicroRNA-492 overexpression involves in cell proliferation, migration, and radiotherapy response of cervical squamous cell carcinomas.miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples.MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting β-catenin and Wnt signaling.miRNA‑222 promotes liver cancer cell proliferation, migration and invasion and inhibits apoptosis by targeting BBC3.
P2860
Q26771827-4449061A-FEC3-4A79-A6BB-6A8A1B7DA95CQ33613535-C6FC6E7F-9C48-4B8B-805C-59D12A180E73Q34007013-66FF3077-6473-4B56-AF4F-8644DF7804A5Q34233531-2ACF73A5-D9B5-4D41-BA72-E1940721C112Q34241079-B29F1B99-64E6-4B95-BEC1-6D356A5145EFQ34578702-DAA59D1F-0D64-4841-9400-B08DAAFC311BQ35042608-5D0D0C69-E52D-409F-9CFD-E8DDF3F64884Q35536045-E62FD2D1-D863-4D68-A5BD-2133BCF65E28Q35678587-8C4980EB-4681-4CF9-A2F9-9BD74BF77CD7Q35995967-528958E3-4757-4E2D-93FE-E2D58FCE015FQ36902949-37290B65-9FD6-4966-9D38-38AF75AAF9CDQ37490764-C8512331-74B0-4CEB-92AA-D65638845051Q37521280-C3C4474B-5C26-4066-8BB2-07456F22877BQ38027114-C11497AC-4690-4944-83A1-929A62B10D4AQ38383322-2D33AB78-BC8D-448A-A0CD-04247DF01FD4Q38768383-3056A745-0D7F-4B9D-BFC7-081FE509233DQ38888749-76A0B8F4-D344-4D0B-A5D7-5BB18ADC1FD9Q38939459-D139903D-D515-44AB-A265-09E6DEC44FFAQ38950381-59059E3D-F502-4581-A660-FE00AB34F8D7Q39275455-7E6A67BC-1BB6-400E-85AE-519B736E0CA6Q40985945-7BD5794A-2539-401E-BCDB-FBAA7D960EBDQ47961443-6F87D50C-044A-4340-8939-CD103F670078Q48000348-C1294BF3-6EB4-46A8-929F-2B03F93F09BDQ51742707-993EF860-F134-40E7-B580-1C296701FC4DQ52716876-574227AA-71B4-466E-8AA5-A8B5624F3F72
P2860
MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
MicroRNA-492 is processed from ...... in metastatic hepatoblastoma.
@ast
MicroRNA-492 is processed from ...... in metastatic hepatoblastoma.
@en
MicroRNA-492 is processed from ...... in metastatic hepatoblastoma.
@nl
type
label
MicroRNA-492 is processed from ...... in metastatic hepatoblastoma.
@ast
MicroRNA-492 is processed from ...... in metastatic hepatoblastoma.
@en
MicroRNA-492 is processed from ...... in metastatic hepatoblastoma.
@nl
prefLabel
MicroRNA-492 is processed from ...... in metastatic hepatoblastoma.
@ast
MicroRNA-492 is processed from ...... in metastatic hepatoblastoma.
@en
MicroRNA-492 is processed from ...... in metastatic hepatoblastoma.
@nl
P2093
P2860
P356
P1433
P1476
MicroRNA-492 is processed from ...... in metastatic hepatoblastoma.
@en
P2093
Adelbert Roscher
Dietrich von Schweinitz
Irene Schmid
Julia von Frowein
Philipp Pagel
P2860
P304
P356
10.1002/HEP.24125
P407
P577
2011-02-11T00:00:00Z